The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-8.2% to $166.00
Predicted High$181.50in 2 weeks
Predicted Low$166.00at 6 months
Max Drawdown (predicted)-8.2%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 7, 2026 1:08 am
Bear
BMO trends lower to
$166.00
(-8.2% from $180.82)
by Feb 2027.
ride-then-fade
ThesisBMO trades ~30% above composite fair value after a strong 28% rally, but low beta and risk-on tape limit near-term downside. Expect a modest fade toward value gravity over 6 months, with the Q3 print as the main catalyst for the first leg lower.
Invalidated ifA clean Q3 beat with credit metrics improving that pushes shares above $195 would invalidate the fade thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $180.82 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 7, 2026
—
$180.82at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 21, 2026
$174.61–$187.03typical range · internal point $181.50
—
±3.4%
6/10
Risk-on tape and momentum carry near term
What actually happened:
closed $172.90
on Aug 20, 2026 = -4.4% vs the call
(predicted +0.4%)
· direction HIT
(called flat, was flat)
· off by 4.8 pp
· accuracy 8/10
· typical range ±3.4%:
OUTSIDE the band
· S&P -1.5%
over the same window — lagged it
1 month
Sep 7, 2026
$171.82–$189.82typical range · internal point $179.00
—
±5.0%
5/10
Modest drift as rally exhaustion sets in
2 months
Oct 7, 2026
$175.50
—
-2.9%
5/10
Q3 print risk and rate/credit crosscurrents weigh
3 months
Nov 7, 2026
$172.00
—
-4.9%
6/10
Post-earnings digestion begins value convergence
4 months
Dec 7, 2026
$170.00
—
-6.0%
5/10
Year-end positioning trims extended winners
5 months
Jan 7, 2027
$168.50
—
-6.8%
4/10
January reset toward signal-adjusted fair value
6 months
Feb 7, 2027
$166.00
—
-8.2%
4/10
Continued gravitation toward $148 anchor, low beta slows drift
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$173.05
(-4.3%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.